Mesenchymal stem cell‐derived exosomes improve neurogenesis and cognitive function of mice with methamphetamine addiction: A novel treatment approach
Exosomen aus mesenchymalen Stammzellen verbessern Neurogenese und kognitive Funktion bei Mäusen mit Methamphetaminabhängigkeit: ein neuartiger Behandlungsansatz
CNS Neuroscience & Therapeutics · 2024-05 · 30 (5)
DOI: 10.1111/cns.14719 ↗Auf einen Blick
Bei männlichen BALB/c-Mäusen mit chronischer Methamphetaminabhängigkeit verbesserten Exosomen aus Knochenmark-MSCs räumliches und Wiedererkennungsgedächtnis. Gleichzeitig nahmen Marker der Neurogenese zu und Entzündungsmarker ab.
Fragestellung
Verbessern Exosomen aus mesenchymalen Stammzellen die kognitive Funktion und Neurogenese bei methamphetaminabhängigen Nagern?
Methode
Männliche BALB/c-Mäuse mit chronischer Methamphetaminabhängigkeit erhielten intravenös Exosomen aus Knochenmark-MSCs. Raum- und Wiedererkennungsgedächtnis, hippocampale Marker und Entzündungszytokine wurden untersucht.
Ergebnisse
Die Exosomen erhöhten im Barnes Maze die Verweildauer im Zielquadranten und die korrekte-zu-falsche Relativzeit. Im NORT verbesserten sich DI und RI; NeuN und DCX stiegen, TNF-α, NF-κB und Iba-1 sanken.
Schlussfolgerung der Autor:innen
Die Autor:innen kommen zu dem Schluss, dass BMSC-Exosomen die durch Methamphetamin verursachte kognitive Dysfunktion durch Förderung der Neurogenese und Hemmung der Neuroinflammation im Hippocampus abschwächten.
Kernaussagen
- Barnes Maze: bessere Leistung nach BMSC-Exosomen
- NORT: DI und RI verbessert
- NeuN/DCX höher, TNF-α, NF-κB und Iba-1 niedriger
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, online erschienen am 23.05.2024. Verfasst von Solmaz Fallahi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. Hauptthemen laut MEDLINE: Exosomes, Neurogenesis, Doublecortin Protein, Methamphetamine. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Drug Applied Research Center, Tabriz University of Medical Sciences.
Themen: Sucht und Abhängigkeit
Abstract (Originalsprache)
Background
Methamphetamine (METH) is a psychostimulant substance with highly addictive and neurotoxic effects, but no ideal treatment option exists to improve METH‐induced neurocognitive deficits. Recently, mesenchymal stem cells (MSCs)‐derived exosomes have raised many hopes for treating neurodegenerative sequela of brain disorders. This study aimed to determine the therapeutic potential of MSCs‐derived exosomes on cognitive function and neurogenesis of METH‐addicted rodents.
Methods
Male BALB/c mice were subjected to chronic METH addiction, followed by intravenous administration of bone marrow MSCs‐derived exosomes. Then, the spatial memory and recognition memory of animals were assessed by the Barnes maze and the novel object recognition test (NORT). The neurogenesis‐related factors, including NeuN and DCX, and the expression of Iba‐1, a microglial activation marker, were assessed in the hippocampus by immunofluorescence staining. Also, the expression of inflammatory cytokines, including TNF‐α and NF‐κB, were evaluated by western blotting.
Results
The results showed that BMSCs‐exosomes improved the time spent in the target quadrant and correct‐to‐wrong relative time in the Barnes maze. Also, NORT's discrimination index (DI) and recognition index (RI) were improved following exosome therapy. Additionally, exosome therapy significantly increased the expression of NeuN and DCX in the hippocampus while decreasing the expression of inflammatory cytokines, including TNF‐α and NF‐κB. Besides, BMSC‐exosomes down‐regulated the expression of Iba‐1.
Conclusion
Our findings indicate that BMSC‐exosomes mitigated METH‐caused cognitive dysfunction by improving neurogenesis and inhibiting neuroinflammation in the hippocampus.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
- Department of Physiology, Tabriz University of Medical Sciences, Tabriz, Iran.
- Department of Neuroscience and Cognition, Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran.
- Neurosciences Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
- Department of Applied Cell Sciences, Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran.
- Department of Biomedical Education, California Health Sciences University, College of Osteopathic Medicine, Clovis, California, USA.
ORCID-Profile: Hamid Soltani Zangbar, Fariba Ghiasi, Gisou Mohaddes
Förderung
- Drug Applied Research Center, Tabriz University of Medical Sciences
Zitieren
APA
Fallahi, S., Zangbar, H. S., Farajdokht, F., Rahbarghazi, R., Ghiasi, F., & Mohaddes, G. (2024). Mesenchymal stem cell‐derived exosomes improve neurogenesis and cognitive function of mice with methamphetamine addiction: A novel treatment approach. CNS Neuroscience & Therapeutics, 30(5). https://doi.org/10.1111/cns.14719
Vancouver
Fallahi S, Zangbar HS, Farajdokht F, Rahbarghazi R, Ghiasi F, Mohaddes G. Mesenchymal stem cell‐derived exosomes improve neurogenesis and cognitive function of mice with methamphetamine addiction: A novel treatment approach. CNS Neuroscience & Therapeutics. 2024;30(5). doi:10.1111/cns.14719
BibTeX
@article{Fallahi2024,
author = {Fallahi, Solmaz and Zangbar, Hamid Soltani and Farajdokht, Fereshteh and Rahbarghazi, Reza and Ghiasi, Fariba and Mohaddes, Gisou},
title = {Mesenchymal stem cell‐derived exosomes improve neurogenesis and cognitive function of mice with methamphetamine addiction: A novel treatment approach},
journal = {CNS Neuroscience & Therapeutics},
year = {2024},
volume = {30},
number = {5},
doi = {10.1111/cns.14719}
}
EUVIMED